主页文献库搜索
De novo resistance biomarkers to anti-HER2 therapies in HER2-positive breast ...

Madrid-Paredes(Adela),Cañadas-Garre(Marisa... Pharmacogenomics 2016-06-16

...PIK3CA or AKT1, cannot be fully established yet.

HER2 activating mutations are targets for colorectal cancer treatment.

Kavuri(Shyam M),Jain(Naveen),Galimi(France... Cancer Discov 2016-05-05

...PIK3CA) wild-type (WT) colorectal cancer patient-derived xenografts (PDX) identified 4 PDXs with HER2 mutations. HER2-ta...

Alteration in PI3K/mTOR, MAPK pathways and Her2 expression/amplification is m...

Mahdi(Haider),Xiu(Joanne),Reddy(Sandeep K)... J Surg Oncol 2016-01-18

...PIK3CA (29% vs. 2%, P < 0.001), FBXW7 (12% vs. 1%, P < 0.001), KRAS (9% vs. 5%, P < 0.001) PTEN (7% vs. 1%, P < 0.001), ...

A Molecular Portrait of High-Grade Ductal Carcinoma In Situ.

Abba(Martin C),Gong(Ting),Lu(Yue),Lee(Jaeh... Cancer Res 2016-01-04

...PIK3CA (21% of cases), TP53 (17%), GATA3 (7%), MLL3 (7%) and single cases of mutations affecting CDH1, MAP2K4, TBX3, NF1...

Precise Classification of Cervical Carcinomas Combined with Somatic Mutation ...

Spaans(Vivian M),Trietsch(Marjolijn D),Pet... PLoS One 2016-05-13

...PIK3CA (20%) and KRAS (7%). PIK3CA mutations occurred more frequently in SCC than AC (25% vs. 11%, P=0.025), whereas KRA...

The histiocytosis Erdheim-Chester disease is an inflammatory myeloid neoplasm...

Haroche(Julien),Cohen-Aubart(Fleur),Charlo... Expert Rev Clin Immunol 2016-05-31

...PIK3CA) have recently been described. These mutations should lead to a new classification of histiocytic disorders such ...

Unique Genetic and Survival Characteristics of Invasive Mucinous Adenocarcino...

Shim(Hyo Sup),Kenudson(Mari-),Zheng(Zongli... J Thorac Oncol 2016-05-19

...PIK3CA mutations. Unexpectedly, we found only two cases with TP53 mutation, which is much lower than observed in lung ad...

Analysis of the molecular features of rectal carcinoid tumors to identify new...

Mitsuhashi(Kei),Yamamoto(Itaru),Kurihara(H... Oncotarget 2016-09-22

...PIK3CA or any microsatellite instability (MSI); however, we did observe CpG island methylator phenotype (CIMP) positivit...

Identification and characterization of RET fusions in advanced colorectal can...

Le Rolle(Anne-France),Klempner(Samuel J),G... Oncotarget 2016-08-10

...PIK3CA or other fusion tyrosine kinases. Multiple RET kinase inhibitors were cytotoxic to RET fusion kinase positive can...

A combination of molecular markers and clinical features improve the classifi...

Springer(Simeon),Wang(Yuxuan),Dal Molin(Ma... Gastroenterology 2016-04-07

...PIK3CA, RNF43, SMAD4, TP53, and VHL); to identify loss of heterozygozity at CDKN2A, RNF43, SMAD4, TP53, and VHL tumor su...

上一页 106 107 108 109 110 111 112 113 114 下一页 110 / 共 350

联系地址

山东省济南市章丘区文博路2号

齐鲁师范学院 genelibs生信实验室

山东省济南市高新区舜华路750号

大学科技园北区F座4单元2楼

电话: 0531-88819269

微信公众号

关注微信订阅号,实时查看信息,关注医学生物学动态。


商务邮箱

E-mail: product@genelibs.com